NMC Health Plc Response to share price movement (8747B)
February 04 2020 - 2:01AM
UK Regulatory
TIDMNMC
RNS Number : 8747B
NMC Health Plc
04 February 2020
4 February 2020
NMC Health plc
(the "Company" or "NMC")
Response to share price movement
NMC Health PLC ("NMC" or the "Company") notes the decline in the
Company's share price yesterday and confirms that it knows of no
specific reason for the fall. The independent review being
undertaken by Freeh Group International Solutions LLC, announced on
17 January 2020, is proceeding. The Company's operations continue
to perform strongly and the Company expects to report full-year
2019 results in-line with management's expectations.
Contacts
NMC
Asjad Yahya, Investor Relations +971 (0)56 219 0975
Media
FTI Consulting, London
Edward Bridges / Simon Conway / Victoria
Foster Mitchell +44 (0)20 3727 1000
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
About NMC Health
NMC is one of the leading private healthcare operators in the
Gulf Cooperation Council ("GCC") with an international network of
multi-specialty inpatient and outpatient clinics and hospitals,
specialized maternity and fertility clinics, and long-term care
homes hospitals across nineteen countries. NMC also ranks as one of
the top two in-vitro fertilisation operators globally. The NMC
Health group is recognised as a leading provider of long-term
medical care in the UAE through its subsidiary ProVita. Pursing a
selective international expansion programme since 2016, NMC has
total capacity of 2,207 licensed beds across its network. Moreover,
the recent formation of a joint venture with GOSI/Hassana
Investment Company provides a solid platform for continued growth
in the GCC region's largest healthcare market. The NMC Health group
treated over 7.5 million patients in 2018. The NMC Health group is
also a leading UAE supplier of products and consumables coming from
healthcare related products. NMC reported revenues of US$2.1
billion for the year ended 31 December 2018.
In April 2012, NMC was listed on the Premium Segment of the
London Stock Exchange. NMC is a constituent of the FTSE 100
Index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
SPMGLGDDISGDGGS
(END) Dow Jones Newswires
February 04, 2020 02:01 ET (07:01 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024